Dynavax to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6, 2020
July 30 2020 - 4:05PM
Dynavax Technologies Corporation (Nasdaq: DVAX), a
biopharmaceutical company focused on developing and commercializing
novel vaccines, will report second quarter 2020 financial results
on Thursday, August 6, 2020, after the U.S. financial markets
close.
Dynavax will host a conference call and live
audio webcast on Thursday, August 6, 2020 at 4:30 p.m. (ET)/1:30
p.m. (PT).
The live audio webcast may be accessed through
the “Events & Presentations” page on the “Investors” section of
the Company’s website at www.dynavax.com. Alternatively,
participants may dial (866) 420-4066 (domestic) or (409) 217-8237
(international) and refer to conference ID 8187870. A replay
of the webcast will be available for 30 days following the live
event.
About DynavaxDynavax is a
commercial stage biopharmaceutical company developing and
commercializing novel vaccines. The Company launched its first
commercial product, HEPLISAV-B® [Hepatitis B Vaccine (Recombinant),
Adjuvanted], in February 2018, following U.S. FDA approval for
prevention of infection caused by all known subtypes of hepatitis B
virus in adults age 18 years and older. Dynavax is also
advancing CpG 1018 as a premier vaccine adjuvant through research
collaborations and partnerships. Current collaborations
are focused on adjuvanted vaccines for COVID-19, pertussis and
universal influenza. For more information, visit www.dynavax.com
and follow the company on LinkedIn.
Contacts:Nicole Arndt, Senior Manager, Investor
Relationsnarndt@dynavax.com510-665-7264
Derek Cole, President Investor Relations Advisory Solutions
derek.cole@IRadvisory.com
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dynavax Technologies (NASDAQ:DVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024